Empowering Small Molecule Drug Discovery by Automatic DEL Screening
In this webinar, our expert speakers showcase our automatic DNA-encoded library (DEL) screening device, DELman.
DNA-encoded library technology has proven to be a powerful tool for drug discovery. There are now several DEL-derived candidates in clinical stage. DEL enables researchers to explore vast chemical space with millions to billions of compounds. With DELman and other self-service data analysis tools, we show how researchers can wield DEL screens in appointed scenarios to obtain stable and reliable screening outcomes.
Related Content
Molecular glues are molecules that can encourage two proteins to interact when they otherwise may not. As a consequence, they...
VIEW RESOURCETarget deconvolution, particularly when paired with proteomics techniques, plays a crucial role in drug discovery and target identification. By using...
VIEW RESOURCE